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ABSTRACT
Generalized arterial calcification of infancy (GACI) is an autosomal recessive 
disorder caused by mutations in the ENPP1 gene. It is characterized by mineralization 
of the arterial blood vessels, often diagnosed prenatally, and associated with death 
in early childhood. There is no effective treatment for this devastating disorder. We 
previously characterized the Enpp1asj mutant mouse as a model of GACI, and we 
have now explored the effect of elevated dietary magnesium (five-fold) in pregnant 
mothers and continuing for the first 14 weeks of postnatal life. The mothers were 
kept on either control diet or experimental diet supplemented with magnesium. 
Upon weaning at 4 weeks of age the pups were placed either on control diet or high 
magnesium diet. The degree of mineralization was assessed at 14 weeks of age 
by histopathology and a chemical calcium assay in muzzle skin, kidney and aorta. 
Mice placed on high magnesium diet showed little, if any, evidence of mineralization 
when their corresponding mothers were also placed on diet enriched with magnesium 
during pregnancy and nursing. The reduced ectopic mineralization in these mice was 
accompanied by increased calcium and magnesium content in the urine, suggesting 
that magnesium competes calcium-phosphate binding thereby preventing the mineral 
deposition. These results have implications for dietary management of pregnancies in 
which the fetus is suspected of having GACI. Moreover, augmenting a diet with high 
magnesium may be beneficial for other ectopic mineralization diseases, including 
nephrocalcinosis. 
INTRODUCTION
Ectopic mineralization, i.e., deposition of calcium 
and phosphate complexes in soft connective tissues, 
represents a broad class of diseases and a significant 
medical problem [1, 2]. These diseases include hardening 
of the arteries associated with aging, chronic kidney 
disease, osteoarthritis, cancer, diabetes, and autoimmune 
diseases. Ectopic mineralization, particularly when 
affecting the cardiovascular system, is a major cause 
of morbidity and mortality. For example, it has been 
demonstrated that coronary artery calcification in a cohort 
of 25,253 patients was an independent risk factor to 
death, the relative risk being up to 12.5-fold [1]. Vascular 
calcification is a common complication in calciphylaxis, a 
highly morbid disorder seen mostly in patients with chronic 
kidney disease [3]. There are two forms of pathological 
mineralization involving peripheral connective tissues. 
Metastatic calcification results from elevated serum levels 
of phosphate and/or calcium exceeding the homeostatic 
capacity of cells and tissues, in conditions such as chronic 
renal failure and hyperparathyroidism. In dystrophic 
calcification, serum calcium and/or phosphate levels are 
normal, but calcification is a secondary consequence of 
trauma to the tissues, for example in autoimmune diseases, 
such as systemic lupus erythematosus, scleroderma and 
dermatomyositis [4]. Dystrophic calcification is also 
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frequently noted in diseased tissue, such as chronic 
ulcers and granulomas as well as in benign and malignant 
neoplasms. Collectively, ectopic mineralization is 
a consequence of a number of contributing genetic, 
metabolic, and environmental factors which has made 
uncovering the precise molecular basis and clinical 
management of these disorders exceedingly difficult. 
A number of heritable ectopic mineralization 
disorders and their corresponding mouse models, as 
exemplified by generalized arterial calcification of 
infancy (GACI), provide insight into the pathophysiology 
of soft tissue mineralization under normal calcium and 
phosphate homeostasis [5, 6]. GACI is a rare heritable 
disease characterized by prenatal onset of widespread 
mineralization of large and medium-sized arteries, 
resulting in cardiovascular collapse and death in the 
neonatal period [7]. GACI is often diagnosed prenatally 
through ultrasound, and the newborns manifest with 
severe hypertension, cardiomyopathy and heart failure, 
resulting in demise of the affected individuals in most 
cases during the first year of life [8]. GACI is caused in 
most cases by loss-of-function mutations in the ENPP1 
gene, which codes for ectonucleotide pyrophosphatase/
phosphodiesterase 1 (ENPP1), an extracellular 
membrane bound glycoprotein that hydrolyzes adenosine 
triphosphate into adenosine monophosphate and inorganic 
pyrophosphate (PPi) [9, 10]. In the absence of the ENPP1 
activity, plasma levels of PPi, a powerful inhibitor of 
ectopic mineralization, are significantly reduced, and 
therefore, progressive vascular mineralization takes 
place. In addition, ENPP1 mutations have been identified 
in some patients with pseudoxanthoma elasticum (PXE), 
another heritable ectopic mineralization disorder, although 
most cases with this disorder harbor mutations in the 
ABCC6 gene [6, 11].
There is no effective or specific treatment for 
GACI. A few studies have suggested that administration 
of bisphosphonates, stable and non-hydrolyzable PPi 
analogues, might be helpful in counteracting the ectopic 
mineralization and reducing mortality in GACI [8, 12, 
13]. However, a potential complication of this approach 
is the severe skeletal toxicity associated with prolonged 
use of bisphosphonates in patients with GACI [14]. Lack 
of consensus about the efficacy of these compounds and 
limited available data make it difficult to determine if 
bisphosphonates offer a safe and effective treatment for 
GACI. 
A number of mouse models, both spontaneous 
and genetically engineered, have been described to 
recapitulate the clinical features of human GACI due 
to genetic alterations in the ENPP1 gene. One of them, 
the Enpp1asj mouse (hereafter referred to as asj), was 
recently identified as a result of ENU treatment in The 
Jackson Laboratory Neuromutagenesis Program [15]. 
Pathological examination of these mice revealed a stiff 
posture, unbendable joints in the front legs with severe 
osteoarthritis and mineralization, and consequently, this 
mutant mouse was designated as ‘‘ages with stiffened 
joints (asj)’’. These mice harbor a homozygous missense 
mutation in the Enpp1 gene (p.V246D) that results in 
markedly reduced ENPP1 enzymatic activity and lowered 
plasma PPi concentration that subsequently allows for 
ectopic mineralization of soft connective tissues in the 
skin and arterial blood vessels to ensue [15]. Previous 
studies in Abcc6-/- mouse model of PXE revealed that an 
increase in dietary magnesium by five-fold over that in 
control diet completely abolished ectopic mineralization 
in the skin [16, 17]. In this study, we investigated the 
effects of dietary magnesium supplementation on ectopic 
mineralization in the skin and vascular tissues in asj mice, 
a model for GACI which shares genotypic and phenotypic 
overlap with PXE. Our results suggest that dietary 
magnesium supplementation, if administered during 
pregnancy and continue to postnatal period, may provide 
an effective way to counteract ectopic mineralization that 
causes considerable mortality in GACI.
RESULTS
High magnesium content in the diet prevents 
ectopic mineralization in the offspring
In this study, we tested the hypothesis that diet 
augmented with magnesium might counteract the ectopic 
mineralization in the skin and vascular tissues, using asj 
mice as a preclinical platform. Pregnant mothers were 
placed on either control diet or magnesium enriched 
diet during the entire pregnancy and the subsequent 
postpartum period. Wild type and asj mice at 4 weeks 
of age at weaning were placed on specific diets, either 
control diet or high magnesium diet for additional 10 
weeks, as indicated in Table 1. At the age of 14 weeks, 
tissue mineralization was determined in the asj offspring. 
We have previously demonstrated that the asj mice 
on control diet develop stiffening of the joints, particularly 
the forepaws, which resulted in a slow, hobbling gait that 
worsened as they aged (Figure 1, group B), a finding 
that was not present wild type mice (Figure 1, group A) 
[15]. Among all groups that were tested, the asj mice fed 
high magnesium diet whose mothers were also fed high 
magnesium diet (Figure 1, group E) showed less stiffened 
phenotype of their forepaws when examined at 14 weeks 
of age. The mice were sacrificed, and muzzle skin, kidneys 
and aorta were harvested for mineralization analysis.
The effect of diet enriched with magnesium on 
ectopic mineralization was assessed by two independent 
examinations. The left side muzzle skin, left kidney and 
descending thoracic aorta were collected and processed 
for semi-quantitative histopathological examinations. 
The degree of mineralization in right side muzzle skin, 
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right kidney and abdominal aorta was quantified by a 
direct chemical assay of calcium content in solubilized 
tissues. Specifically, Alizarin red stains in wild type mice 
did not show any signs of mineralization (group A, data 
not shown), while extensive mineralization was noted 
in the dermal sheath of vibrissae in muzzle skin, kidney 
and aorta in asj mice on control diet whose mothers were 
also placed on control diet (Figure 2, group B). Elevated 
magnesium content in the maternal diet (five-fold) resulted 
in significantly reduced mineralization in asj offspring 
who were also placed on high magnesium diet (Figure 2, 
group E). The difference in tissue mineralization was also 
demonstrated by quantitative assay of calcium content in 
these tissues. High magnesium content in the diet of asj 
pups post weaning (Figure 3, group C) or in the maternal 
diet alone (Figure 3, group D) did not appreciably change 
the degree of mineralization in muzzle skin and aorta, 
as compared to the corresponding mice fed control diet 
(Figure 3, group B). In contrast, the asj mice fed a high 
magnesium diet with mothers on the same diet (Figure 3, 
group E) showed significantly reduced amount of calcium 
in muzzle skin, kidney and aorta, and quantitatively the 
calcium values were at the same low level as noted in wild 
type mice (Figure 3, group A). In addition, the asj mice 
fed a high magnesium diet whose mothers were on control 
diet also showed markedly reduced calcium content in the 
kidney (Figure 3, group C). Collectively, histopathologic 
analyses and quantitative calcium determinations 
demonstrated that elevated magnesium content (five-fold) 
in the diet prevents ectopic mineralization in asj offspring 
with mutations in the Enpp1 gene. 
The magnesium content in the tissues was also 
assessed in asj mice as a result of feeding on magnesium-
supplemented diet. The tissues from asj mice on control 
diet (group B) and high magnesium diet (group E) 
were analyzed at 14 weeks of age. First, the elemental 
composition in muzzle skin sections was analyzed 
by energy dispersive X-ray of the mineralized areas 
in the vibrissae. The analysis revealed calcium and 
phosphorus as the principal ions in the tissues (Figure 4). 
Figure 1: Magnesium treatment improves the stiffened joints phenotype in asj mice at 14 weeks of age. The asj mice on 
control diet (group B) develop stiffening of the joints leading to contractures as shown on the front paws (arrows) in comparison with a 
corresponding wild type mouse (group A). The asj mice on high magnesium diet whose mothers were also placed on the same diet during 
pregnancy and nursing had improved phenotype of stiffening of the joints in the front paws (group E).
Table 1: Experimental groups of Enpp1asj mice by genotype and treatment1)
Group Genotype of pups Diet pregnant mothers placed on Diet pups placed on No. of pups examined (M+F)
A WT control control 9 (6+3)
B asj control control 10 (5+5)
C asj control High Mg 11 (6+5)
D asj High Mg control 13 (6+7)
E asj High Mg High Mg 12 (6+6)
1)The pregnant mothers were placed on either control diet or magnesium-supplemented diet (high Mg diet) during pregnancy 
and nursing. The pups, at 4 weeks of weaning, were assigned to either control diet or high Mg diet for additional 10 weeks. 
The mice were sacrificed at the age of 14 weeks for mineralization analysis. WT, wild type; M, male; F, female.
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Topographic mapping revealed that these ions co-localize 
in the mineralized connective tissue capsule, suggesting 
the presence of hydroxyapatite. Magnesium does not 
constitute for the major element in the tissues, and in 
fact, as compared to calcium and phosphorus, magnesium 
signal is extremely low (Figure 4). Second, the amount 
of magnesium was quantitatively measured in solubilized 
muzzle skin, kidney and abdominal aorta samples. The 
amount of magnesium (µmol Mg/gram tissue) was not 
statistically different: 22.6 ± 0.9 and 21.6 ± 2.4 for muzzle 
skin, 15.3 ± 1.1 and 16.2 ± 1.3 for kidney, and 7.8 ± 0.4 
and 7.6 ± 0.4 for abdominal aorta, from asj mice in groups 
B and E, respectively (mean ± SE). 
High magnesium content in the diet alters serum 
and urinary mineral profiles
To examine the metabolic consequences of the 
experimental diets, the serum and urine concentrations 
of calcium, phosphorus and magnesium were determined 
in mice at the end of the 14-week experimental diet. 
No significant differences were noted in the serum 
concentrations of these components (Table 2). In contrast, 
significant changes were noted in calcium, phosphorus, 
and magnesium concentrations in the urine of mice 
after feeding with magnesium. Specifically, over 24-fold 
increase in calcium concentration and > 85% reduction 
in the phosphorus concentration were noted in asj mice 
Table 2: Calcium, phosphorus, and magnesium concentrations in the serum and urine of mice1)
Group
Serum concentration Urine concentration
Calcium 
(mg/dL)
Phosphorus 
(mg/dL)
Magnesium 
(mg/dL)
Calcium 
(mg/dL)
Phosphorus 
(mg/dL)
Magnesium 
(mg/dL)
A 10.8 ± 0.2 6.5 ± 0.4 3.5 ± 0.1 3.4 ± 0.7 89.9 ± 18.0 43.9 ± 3.4
B 10.6 ± 0.1 6.7 ± 0.6 4.3 ± 0.4 4.1 ± 0.6 116.1 ± 13.0 51.9 ± 2.3
C 10.3 ± 0.4 5.2 ± 0.6 4.8 ± 0.3 99.7 ± 16.6** 16.4 ± 3.2** 61.6 ± 0.3**
D 10.9 ± 0.2 6.2 ± 0.3 4.1 ± 0.2 4.5 ± 0.5 141.1 ± 14.4 46.0 ± 1.9
E 10.9 ± 0.1 7.2 ± 0.4 4.5 ± 0.1 103.7 ± 18.4** 9.0 ± 1.4** 61.5 ± 0.2**
1)Data are expressed as means ± SE; n = 8-13 mice per group. ** P < 0.01, as compared with asj mice on control diet in group 
B. For description of different groups, see Table 1.
Figure 2: Magnesium treatment prevents ectopic soft tissue mineralization in asj mice as revealed by histopathology. 
The asj mice and their respective mothers placed on control diet develop ectopic mineralization of the dermal sheath of vibrissae in muzzle 
skin, kidney and aorta, when examined at 14 weeks of age by histopathology with Alizarin red stain (group B). Markedly reduced mineral 
deposition was noted in asj mice fed high magnesium diet when their respective mothers were also placed on high magnesium diet during 
pregnancy and nursing (group E). Scale bar = 0.4 mm.
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fed high magnesium diet (Table 2, groups C and E). In 
addition, the concentration of urinary magnesium was 
significantly increased in asj mice fed high magnesium 
diet (Table 2, groups C and E). Feeding mice with 
elevated magnesium content resulted in more calcium 
and magnesium excreted into urine, suggesting direct 
interactions by which magnesium and calcium ions 
compete in phosphorus binding leading to more soluble 
magnesium phosphate complexes.
High magnesium content in the diet does not 
cause hormonal and metabolic alterations
As inhibition of ectopic mineralization by 
magnesium could involve changes in the parathyroid 
hormone (PTH) action [18], we also measured the serum 
concentrations of PTH by an ELISA assay in mice fed 
control diet or diet enriched in magnesium at the end of 
the experimental diet. Although individual variability in 
PTH values was noted, the average concentrations were 
not statistically different in different groups (Table 3). 
Table 3: Measurements of serum PTH and urinary albumin1)
Group Serum PTH (pg/mL) Urine albumin (g/dL)
A 56.8 ± 8.7 < 0.01
B 44.2 ± 7.6 < 0.01
C 47.0 ± 13.3 < 0.01
D 61.6 ± 9.3 < 0.01
E 38.9 ± 4.7 < 0.01
1)Data are expressed as means ± SE; n = 8-13 mice per group. No statistical differences are noted as compred to the asj mice 
on control diet in group B. PTH, parathyroid hormone. The urinary albumin levels are below the detection limit of 0.01 g/dL. 
For description of different groups, see Table 1.
Figure 3: Magnesium treatment reduces ectopic soft tissue mineralization in asj mice as determined by the direct 
chemical assay of calcium. Muzzle skin biopsies, kidney and aorta were harvested and calcium content was quantitated by a chemical 
assay. Note the significantly elevated calcium content in asj mice (group B) as compared with the wild type mice (group A) on the control 
diet. Treatment of asj mice with diet supplemented with magnesium whose pregnant mothers were also kept on the same diet (group E) 
resulted in a significant reduction in the calcium content in these tissues in comparison with the asj mice on control diet (group B). Feeding 
asj mice with magnesium after weaning whose mothers were fed control diet (group C) also significantly reduced the calcium content of 
the kidney as compared with asj mice on control diet (group B). Mean ± SE; n = 9-13 mice per group. * P < 0.05, ** P < 0.01, vs group A; 
+ P < 0.05, ++ P < 0.01, vs group B.
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To determine whether feeding with magnesium 
affects renal function, we measured urinary albumin 
concentrations as an indicator of renal function. In all mice 
analyzed, albumin levels in the urine samples were below 
the detection limit of 0.01 g/dL (Table 3), suggesting 
normal renal function in mice fed with magnesium for up 
to 14 weeks of time.
DISCUSSION
Diseases of ectopic mineralization of connective 
tissues range from rare heritable diseases, such as GACI, 
to common maladies in the ageing population, such as 
arteriosclerosis. The characteristic feature of GACI is 
profound arterial mineralization often diagnosed by 
prenatal ultrasound during pregnancy. The affected 
children are born with cardiovascular complications with 
older reports indicating ~85% mortality rate at 6 months 
of age [19]. Current medical strategies preventing or 
reversing the connective tissue mineralization present in 
GACI are ineffective and novel experimental therapeutics 
are clearly needed. One study reported that intensive 
treatment with bisphosphonates lowered mortality of 
GACI to 55% at 6 months [8], while other studies showed 
very little, if any, effect [20]. Bisphosphonates have 
also been reported to be accompanied by severe side 
effects, particularly on the development of bones [14]. 
The potential efficacy of bisphosphonates has been also 
explored in asj mutant mouse as a preclinical platform 
for GACI. The results demonstrated that bisphosphonate 
treatment may be beneficial by a dual effect for preventing 
ectopic soft tissue mineralization while correcting 
decreased bone mineralization in asj mice [21]. Recently, 
it was shown that recombinant ENPP1-Fc fusion enzyme, 
when administered subcutaneously in asj mice with 
reduced ENPP1 enzymatic activity, prevents mortality and 
vascular mineralization [22]. 
There are several lines of evidence suggesting that 
diet, particularly with respect to its magnesium content, 
may modify the severity of ectopic mineralization. Early 
studies using transgenic mice with targeted ablation of 
the Abcc6 gene as a model for PXE have demonstrated 
that increased levels of magnesium in the diet, five times 
over the standard rodent diet, completely abolished the 
ectopic mineralization in these mice [16, 17]. At the same 
time, addition of phosphate, two times over the standard 
diet, when combined with reduced (20%) magnesium 
content, significantly accelerated the mineralization in 
mouse models for PXE and GACI; this diet has been 
designated as the “acceleration diet” [15, 23, 24]. In 
addition, maternal “acceleration diet” during pregnancy 
can influence the degree of ectopic mineralization in the 
offspring [25].
The results of our study clearly demonstrate that 
magnesium, when added to the mouse diet in amounts 
that increase the magnesium concentration by five-fold, 
is able to prevent the ectopic mineralization in skin and 
vascular tissues in asj mice when the mothers are also 
placed on the same diet during pregnancy. When only the 
asj mice were kept on high magnesium diet post-weaning, 
or only the mothers were placed on high magnesium diet 
while pups were maintained on control diet, the efficacy 
of magnesium on preventing mineralization is reduced. 
Supplementation of magnesium in the mouse diet did not 
change serum calcium, phosphorus, and magnesium levels, 
while increased calcium and magnesium concentrations 
were found in the urine. No overt side effects were noted 
in the mice fed with five-fold increase of magnesium 
content in mouse diet. 
Figure 4: Energy dispersive X-ray analysis demonstrates hydroxyapatite in the muzzle skin biopsies containing 
mineral deposits in the dermal sheath of vibrissae. Elemental composition analysis reveals the presence of calcium (Ca) and 
phosphorus (P) as the principal ions in the muzzle skin of asj mice in groups B and E. There is very little magnesium (Mg) present in the 
tissues. The presence of carbon (C) reflects the carbon carrier that holds the samples. X-ray topography of the distribution maps of calcium 
(green) and phosphorus (red) reveals co-localization in the areas of ectopic mineralization. Scale bar = 0.2 mm.
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The mechanisms for the inhibition of ectopic 
mineralization by magnesium could be systemic 
interfering with the calcium metabolism mediated through 
the PTH synthesis and/or secretion. In support of this 
suggestion are observations that magnesium deficiency is 
associated with insufficient PTH action and can lead to 
reduced responses to calcitropic hormones [18]. However, 
determination of serum PTH levels in the treated asj 
mice did not reveal significant differences. An alternate 
mechanism may involve direct interactions between 
magnesium and calcium ions in the mineralization process, 
i.e., magnesium competes calcium-phosphate binding and 
forms magnesium phosphate complexes which are soluble, 
thereby preventing the mineral deposition of calcium 
phosphate complexes. The elevated urinary calcium and 
magnesium results favor the latter hypothesis.
Our observations have implications for the clinical 
management of patients with GACI caused by ENPP1 
mutations. Specifically, the results of our study suggest 
that dietary magnesium might be helpful for treatment 
of patients with GACI. Identification of mutations in 
the ENPP1 gene can be used for confirmation of the 
clinical diagnosis, carrier detection and presymptomatic 
identification of affected individuals with family history 
of GACI. Prenatal genetic testing from chorionic villus 
sampling or from fetal cells in maternal circulation is also 
possible for families with affected individuals. For patients 
with family history, as soon as the clinical diagnosis and 
mutation analysis have been made during pregnancy, 
elevated magnesium in maternal diet might slow down the 
progression of GACI in the fetus and improve the quality 
of postnatal life of patients with this, currently intractable, 
disease. The results from the preclinical mouse model 
of GACI suggest that magnesium supplementation in 
pregnant mothers or the newborn child alone would not be 
sufficient, but rather the pregnant mothers would have to 
receive treatment followed by continued treatment of the 
affected newborn suspected of GACI. It should be noted 
that the daily dose of magnesium administered to the mice 
was higher than the recommended daily dose for humans 
(300-400 mg per day). Thus, the efficacy in humans 
should be tested in controlled clinical trials with careful 
monitoring of side effects. The similar clinical features and 
pathophysiology in GACI and other common conditions 
presenting with vascular mineralization suggests that these 
disorders may be treated by a common approach—dietary 
magnesium treatment.
MATERIALS AND METHODS
Mice and diet
C57BL/6J-Enpp1asj/GrsrJ mice on a C57BL/6J 
background were obtained from The Jackson Laboratory 
(Bar Harbor, ME); these mice are referred to as the asj 
mice [15]. The wild type and homozygous asj mice were 
generated from heterozygous breedings. The mice were 
maintained on standard rodent laboratory diet (Laboratory 
Autoclavable Rodent Diet 5010; PMI Nutritional 
International, Brentwood, MO) under standard conditions. 
Mice were divided into five groups (A, B, C, D and E) 
based on their Enpp1 genotype and treatment regiments. 
Groups A and B were wild type and asj mice, respectively, 
fed a control diet for both pregnant mothers and pups until 
pups became 14 weeks of age. The pregnant mothers in 
group C were fed the control diet during pregnancy and 
nursing. At 4 weeks of weaning, the asj pups were placed 
on diet with a five-fold increase in magnesium for another 
10 weeks. The pregnant mothers in group D were fed the 
high magnesium diet during pregnancy and nursing. At 4 
weeks of weaning, the asj pups were placed on control diet 
for another 10 weeks. The asj mice in group E and their 
corresponding mothers received the high magnesium diet 
during pregnancy and postnatally. At 14 weeks of age, the 
mice were sacrificed for analysis. For different groups, see 
Table 1. 
All protocols were approved by the Institutional 
Animal Care and Use Committee of Thomas Jefferson 
University.
Histopathology of soft connective tissues
Biopsies from muzzle skin containing vibrissae 
(left side) as well as the internal organs (left kidney and 
descending thoracic aorta) were fixed in 10% phosphate-
buffered formalin and embedded in paraffin. Paraffin 
sections (6 µm) were stained with hematoxylin-eosin 
(H&E) and Alizarin red stains using standard methods 
[15].
Quantification of calcium and phosphorus
To quantify the calcium content in mouse tissues, 
muzzle skin biopsies (right side), right kidney, and 
abdominal aorta were harvested and decalcified with in 
HCl solution. The solubilized calcium was determined 
in the HCl supernatants colorimetrically by the 
ơ-cresolphthalein complexone method (Calcium (CPC) 
Liquicolor; Stanbio Laboratory, Boerne, TX). The values 
for calcium were normalized to tissue weight. Calcium in 
the serum and urine samples was quantitatively assayed 
as above. The serum and urinary phosphorus content was 
determined with a Malachite Green Phosphate Assay kit 
(BioAssay Systems, Hayward, CA). 
Quantification of magnesium
The magnesium concentrations in the mouse serum 
and urine were measured using the QuantiChromTM 
Magnesium Assay Kit (BioAssay Systems). The 
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magnesium contents in the HCl supernatants of tissues 
were also measured using this kit.
Energy dispersive X-ray analysis
Paraffin sections of muzzle skin were mounted onto 
carbon carrier and imaged using energy dispersive X-ray 
analysis and topographic mapping [26]. The elemental 
composition was analyzed with a FEI 600 Quanta FEG 
scanning electron microscope (FEI Company, Eindhoven, 
The Netherlands) fitted with an Octane Super SDD EDS 
detector (EDAX, Sandy, UT). X-ray topographic maps 
of calcium and phosphorus were acquired using Spirit 
software version 1.07.05 (Princeton Gamma-Tech, Rocky 
Hill, NJ). 
Serum parathyroid hormone and urinary 
albumin assays
Serum PTH concentrations were measured using 
a Mouse PTH 1-84 ELISA Kit (Immutopics Inc., San 
Clemente, CA). Urinary albumin concentrations were 
determined using a QuantiChromTM BCG Albumin Assay 
Kit (BioAssay Systems). 
Statistical analysis
The results in different groups of mice were 
evaluated by Student’s two-tailed t-test. Statistical 
significance was reached with P < 0.05. Analyses were 
conducted using SAS 9.4 (SAS Institute, Cary, NC).
Abbreviations
GACI, generalized arterial calcification of infancy; 
PXE, pseudoxanthoma elasticum; WT, wild type; asj, ages 
with stiffened joints.
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